Finding into death of Lenin McLarty
Deceased
Lenin McLarty
Demographics
68y, male
Date of death
2007-11-18
Finding date
2013-06-05
Cause of death
Dilated cardiomyopathy with previous aortic valve replacement and aortic graft
AI-generated summary
A 68-year-old man with aortic valve replacement died from undiagnosed dilated cardiomyopathy, with retroperitoneal haemorrhage as a contributing factor. He developed a large perinephric haematoma (1900mL) secondary to over-anticoagulation (INR 3.5, prothrombin 49 seconds) from warfarin. His GP did not receive anticoagulation monitoring results from Austin Health, limiting ability to adjust warfarin dosing. In ED, a registrar appropriately identified over-anticoagulation before CT diagnosis and proactively ordered reversal agents, though Prothrombinex dosing was not documented. Hospital management was appropriate; the haematoma stabilized and patient remained stable until sudden collapse on day 3 in hospital. The preventable clinical lesson is that GPs managing warfarin patients must ensure receipt of INR results and remain alert to bruising and abdominal pain as bleeding signs, especially with elevated INR. ED identification of warfarin toxicity was exemplary.
AI-generated summary and tagging — may contain inaccuracies; refer to original finding for legal purposes.
Error types
Drugs involved
Clinical conditions
Contributing factors
- Retroperitoneal haemorrhage secondary to over-anticoagulation
- Inadequate anticoagulation monitoring by general practitioners
- GP did not receive INR/prothrombin results from Austin Health
- Undiagnosed severe dilated cardiomyopathy
- INR over-elevation (3.5) in the four months preceding presentation
- Failure to document Prothrombinex dose on initial order
- Failure to administer Vitamin K with Prothrombinex reversal
Coroner's recommendations
- No formal recommendations made. Northern Hospital had proactively implemented new Prothrombinex guidelines (17 November 2010), introduced mandatory protocol for anticoagulation reversal (April 2010), conducted audit of Prothrombinex dosing (2011), and committed to six-monthly compliance audits.
Full text
Related cases
Source and disclaimer
This page reproduces or summarises information from publicly available findings published by Australian coroners' courts. Coronial is an independent educational resource and is not affiliated with, endorsed by, or acting on behalf of any coronial court or government body.
Content may be incomplete, reformatted, or summarised. All court orders for redaction and non-publication are respected; documents with technically defective redaction have been excluded from the database entirely. Always refer to the original court publication for the authoritative record.
Copyright in original materials remains with the relevant government jurisdiction. AI-generated summaries and tagging are for educational purposes only, may contain inaccuracies, and must not be treated as legal documents. We welcome feedback for correction —